CD4 and glioblastoma: When compared with 31 pretreatment primary GBM tumors (12 from this study and 19 from a published series20), the ICI-treated posttreatment GBM specimen had the highest proportion of infiltrating CD3+ and CD4+ T cells and among the highest frequency of infiltrating CD8+ T cells.